Champions Oncology Inc (NASDAQ: CSBR) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.25 price target on the stock.
Champions Oncology, Inc. (CSBR)
NASDAQ:AMEX Investor Relations:
championsoncology.com/investors
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
CSBR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CSBR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CSBR alerts
High impacting Champions Oncology, Inc. news events
Weekly update
A roundup of the hottest topics
CSBR
News
- Champions Oncology (NASDAQ:CSBR) shareholders have endured a 61% loss from investing in the stock three years ago [Yahoo! Finance]Yahoo! Finance
- Champions Oncology Announces Agreement with Weill Cornell Medicine [Yahoo! Finance]Yahoo! Finance
- Champions Oncology Announces Agreement with Weill Cornell MedicineAccesswire
- Champions Oncology (NASDAQ:CSBR) Is In A Strong Position To Grow Its Business [Yahoo! Finance]Yahoo! Finance
- Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
CSBR
Earnings
- 12/12/23 - Beat
CSBR
Sec Filings
- 11/18/24 - Form 4
- 11/18/24 - Form 4
- 11/18/24 - Form 4
- CSBR's page on the SEC website